Free Trial
NYSE:UPC

Universe Pharmaceuticals (UPC) Stock Price, News & Analysis

Universe Pharmaceuticals logo
$3.54 -0.04 (-0.98%)
As of 10:09 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Universe Pharmaceuticals Stock (NYSE:UPC)

Key Stats

Today's Range
$3.30
$3.68
50-Day Range
$3.27
$4.29
52-Week Range
$2.51
$2,340.00
Volume
19,086 shs
Average Volume
275,450 shs
Market Capitalization
$2.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive UPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Universe Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

UPC Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
See More Headlines

UPC Stock Analysis - Frequently Asked Questions

Universe Pharmaceuticals' stock was trading at $24.40 at the beginning of the year. Since then, UPC shares have decreased by 85.5% and is now trading at $3.5450.

Shares of Universe Pharmaceuticals reverse split on Wednesday, November 13th 2024.The 1-15 reverse split was announced on Wednesday, November 13th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Universe Pharmaceuticals (UPC) raised $30 million in an initial public offering (IPO) on Tuesday, March 23rd 2021. The company issued 5,000,000 shares at $5.00-$7.00 per share. Univest Securities, LLC acted as the underwriter for the IPO.

Shares of UPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Universe Pharmaceuticals investors own include NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF) and GE Aerospace (GE).

Company Calendar

Today
8/13/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:UPC
CIK
1809616
Fax
N/A
Employees
220
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$19.29 million
Price / Sales
0.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$163.50 per share
Price / Book
0.02

Miscellaneous

Outstanding Shares
563,000
Free Float
731,000
Market Cap
$2.00 million
Optionable
Not Optionable
Beta
1.43
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:UPC) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners